Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
5
FDA:5
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
Phase 3
Completed
- Conditions
- Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
- Interventions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Biocon Biologics Inc.
- Target Recruit Count
- 374
- Registration Number
- NCT05637515
- Locations
- 🇧🇬
Site 407 - Medical Centre "Asklepii", OOD, Dupnitsa, Bulgaria
🇧🇬Site 409 - Medical center Medconsult Pleven OOD, Pleven, Bulgaria
🇧🇬Site 403 - MC Rusemed ltd., Ruse, Bulgaria
News
No news found